David B. McWilliams's most recent trade in Greenwich LifeSciences Inc was a trade of 61,984 Stock Options done . Disclosure was reported to the exchange on Dec. 24, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Greenwich LifeSciences Inc | McWilliams B. David | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Dec 2024 | 61,984 | 123,968 | - | - | Stock Options | |
| Greenwich LifeSciences Inc | David B. McWilliams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 61,984 | 61,984 | - | - | Stock Options | |
| Greenwich LifeSciences Inc | David B. McWilliams | Director | Purchase of securities on an exchange or from another person at price $ 27.56 per share. | 14 Dec 2021 | 200 | 620,301 | - | 27.6 | 5,512 | Common Stock |
| Greenwich LifeSciences Inc | David B. McWilliams | Director | Purchase of securities on an exchange or from another person at price $ 5.40 per share. | 20 Nov 2020 | 1,500 | 620,101 | - | 5.4 | 8,100 | Common Stock |
| Greenwich LifeSciences Inc | David B. McWilliams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 152,604 | 599,583 | - | - | Common Stock | |
| Greenwich LifeSciences Inc | David B. McWilliams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 152,604 | 0 | - | - | Series A Preferred Stock | |
| Greenwich LifeSciences Inc | David B. McWilliams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 7,663 | 0 | - | - | Series B Preferred Stock | |
| Greenwich LifeSciences Inc | David B. McWilliams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 7,663 | 607,246 | - | - | Common Stock | |
| Greenwich LifeSciences Inc | David B. McWilliams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 7,609 | 618,601 | - | - | Common Stock | |
| Greenwich LifeSciences Inc | David B. McWilliams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 6,555 | 0 | - | - | Series D Preferred Stock | |
| Greenwich LifeSciences Inc | David B. McWilliams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 3,746 | 0 | - | - | Series C Preferred Stock | |
| Greenwich LifeSciences Inc | David B. McWilliams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 3,746 | 610,992 | - | - | Common Stock | |
| Greenwich LifeSciences Inc | David B. McWilliams | Director | Purchase of securities on an exchange or from another person at price $ 5.75 per share. | 29 Sep 2020 | 2,608 | 446,979 | - | 5.8 | 14,996 | Common Stock |
| Greenwich LifeSciences Inc | David B. McWilliams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 1,054 | 0 | - | - | Series D Preferred Stock | |
| Greenwich LifeSciences Inc | David B. McWilliams | Director | Other type of transaction at price $ 0.00 per share. | 29 Sep 2020 | 1,054 | 1,054 | - | - | Series D Preferred Stock |